RNAIMMUNE
RNAimmune is a biopharmaceutical company specializing in the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. The company leverages mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. RNAimmune is a spin-off venture from Sirnaomics, Inc. has received a global exclusive right to the proprietary Polypeptide Lipid Nanoparticle (PLNP) technology for mRNA delivery from Sirnaomics. The company has also ... developed a proprietary A.I. algorithm (ALEPVA) for antigen prediction and vaccine design. By integrating multiple established platform technologies, the company is aiming to develop a comprehensive mRNA drug discovery and development platform, from which the company will enrich its therapeutic and vaccine product pipeline addressing tremendous unmet needs in treatments of viral infections, cancer, and rare diseases.
RNAIMMUNE
Industry:
Biotechnology Health Care Life Science
Founded:
2020-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.rnaimmune.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
39.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
BIOMES
BIOMES is a biotechnological pioneer that specializes in improving everyones wellbeing by analyzing and interpreting the human microbiome.
Brain Neurotherapy Bio
Brain Neurotherapy Bio focuses on the clinical translation and development of neurotrophic factor gene therapy.
Cell Vault
Cell Vault offers a t-cell bank that gives healthy individuals an opportunity to jumpstart their fight against cancer.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Evommune
Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines.
ExcepGen
ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.
Gossamer Bio
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Hive
Hive Biosystems helps pharmaceutical companies streamline genetics-driven drug discovery by rapidly generating transgenic animals.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
MRM Health NV
MRM Health NV is a biopharmaceutical company focused on the discovery and development of therapeutics based on the human microbiome.
Ona Therapeutics
Ona Therapeutics is focused on the discovery and development of therapeutic biologics to treat metastatic cancer.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Rubix LS
Rubix LS primary goal is to eradicate rare diseases through transformative research and development, breakthroughs in engineering.
SeromYx Systems
SeromYx Systems provides insight into the immune function to discover and develop vaccines, immunotherapies, drugs, and diagnostics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Rotating Boulder Fund
Rotating Boulder Fund investment in Series A - RNAimmune
Sirnaomics
Sirnaomics investment in Series A - RNAimmune
Smooth River
Smooth River investment in Series A - RNAimmune
Sirnaomics
Sirnaomics investment in Seed Round - RNAimmune
Smooth River
Smooth River investment in Seed Round - RNAimmune
Terra Magnum Capital Partners (""""TMCP"""")""
Terra Magnum Capital Partners (""""TMCP"""")"" investment in Seed Round - RNAimmune
Official Site Inspections
http://www.rnaimmune.com Semrush global rank: 4.24 M Semrush visits lastest month: 2.76 K
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "RNAimmune"
RNAimmune
RNAimmune is a biotechnology startup in the field of messenger RNA (mRNA) technology with more than 20 years’ expertise in handling and optimizing this versatile molecule for medical …See details»
RNAimmune - Crunchbase Company Profile & Funding
RNAimmune is a biopharmaceutical company specializing in the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. The company leverages mRNA as a …See details»
RNAimmune Company Profile 2024: Valuation, Funding
Provider of mRNA (messenger ribonucleic acid)-based therapeutics and vaccines intended to tackle indications in cancer, infectious and rare diseases.See details»
Rnaimmune, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
We investigate the use of in vitro transcription (IVT) for mRNA production, presenting a novel approach to traditional antibody treatments by promoting internal protein or antibody synthesis. …See details»
RNAimmune mRNA Cancer Vaccine Program Accepted for Oral …
Feb 6, 2023 · RNAimmune has extremely high potential and has become one of the leading companies in the field of mRNA vaccines and therapeutics. Learn more at …See details»
RNAimmune | VentureRadar
RNAimmune is a biotechnology startup in the field of messenger RNA (mRNA) technology with more than 20 years’ expertise in handling and optimizing this versatile molecule for medical …See details»
RNAimmune Receives FDA Clearance of Investigational New Drug ...
Apr 27, 2023 · RNAimmune is an international biopharmaceutical company focusing on mRNA vaccine and therapeutics development. Its global headquarter is in Germantown, Maryland, …See details»
RNAimmune Receives Investigational New Drug Application
Dec 18, 2023 · RNAimmune will begin a Phase I clinical study to assess the safety and tolerance of RV-1770, a combination of an mRNA-based vaccine with a proprietary lipid nanoparticle …See details»
RNAimmune Closed Seed Funding of $2.35m for Development of …
Aug 24, 2020 · RNAimmune is a biopharmaceutical company specializing in discovery and development of messenger RNA (mRNA) therapeutics and vaccines. The company leverages …See details»
Services — RNAimmune
RNAimmune currently provides services to facilitate pre-clinical research needs from DNA sequence to animal study: Facilitate your work with : DNA synthesis & plasmid prepSee details»
RNAimmune Secures $27 Million Series A Round of Financing for ...
Mar 30, 2022 · RNAimmune is a biopharmaceutical company specializing in discovery and development of messenger RNA (mRNA) therapeutics and vaccines. The Company leverages …See details»
RNAimmune Receives FDA Clearance of Investigational New Drug ...
Apr 27, 2023 · RNAimmune is an international biopharmaceutical company focusing on mRNA vaccine and therapeutics development. Its global headquarter is in Germantown, Maryland, …See details»
RNAimmune mRNA Cancer Vaccine Program Accepted for Oral
Feb 6, 2023 · RNAimmune will present a pre-clinical study showing the most recent mRNA cancer vaccine progress. The study shows immunization of the mRNA vaccine can elicit T and B cell …See details»
Codex DNA and RNAimmune Announce Collaboration to …
Nov 22, 2021 · RNAimmune is a biopharmaceutical company specializing in the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. The Company leverages …See details»
RNAimmune closes $2.35m seed funding for development of …
RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, announced the completion of its $2.35 million seed …See details»
RNAimmune Receives Investigational New Drug Application …
Dec 19, 2023 · RNAimmune will begin a Phase I clinical study to assess the safety and tolerance of RV-1770, a combination of an mRNA-based vaccine with a proprietary lipid nanoparticle …See details»
COVID-19 mRNA vaccines: Platforms and current developments
In this review, we summarize the preclinical and clinical data of the vaccine candidates, which fall under four mRNA vaccine platforms: non-replicating linear nucleoside-modified and …See details»
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older …
Dec 13, 2023 · Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized RSV …See details»
RNAimmune Secures $27 Million Series A Round of Financing for ...
Mar 29, 2022 · RNAimmune is a biopharmaceutical company specializing in discovery and development of messenger RNA (mRNA) therapeutics and vaccines. The Company leverages …See details»
RNAimmune mRNA Cancer Vaccine Program Accepted for Oral
Feb 7, 2023 · RNAimmune is an international biopharmaceutical company focusing on mRNA vaccine and therapeutics development. Its global headquarter is in Germantown, Maryland, …See details»